Why this research matters
Type 2 studies at Lumos enroll adults at many stages, newly diagnosed, long-managed, or struggling despite multiple medications. Participation includes regular labs, structured monitoring and clinical attention at a frequency routine care rarely offers, at no cost and with no insurance involved.
Is this you?
A study may be worth a conversation if some of this sounds familiar:
Screening is free, confidential and decides nothing by itself. It simply tells you whether a current study fits.
Your path into a study
Common questions
Some current research involves next-generation approaches in that space; other studies investigate different mechanisms entirely. The team will tell you specifically what's enrolling.
Many studies compensate for time and travel. The exact amount is study-specific and stated plainly during consent, before you commit to anything.
Screening will establish where you fit. Some studies enroll early-stage participants; if nothing fits, you'll be told so directly rather than strung along.
Not enrolling for type 2 diabetes right now?
Join the research registry and you’ll be contacted first when a matching study opens. Or explore other areas we’re currently studying:
